title: [Effectiveness of the analgesic, tramal, in the treatment of patients with oncologic diseases].
abstract: Tramal, the drug produced by the "Grunenthal" firm (FRG) was used in the treatment of 478 patients with malignant neoplasms. In 24.46% patients, the side effects were noted, which were characteristic of the majority of analgetics and didn't threaten the life. The authors recommend to use Tramal for cupping off the pain syndrome at the postoperative period, and in incurable patients as well.
authors.forename: V A
authors.initials: VA
authors.lastname: Lisetskiĭ
authors.forename: A P
authors.initials: AP
authors.lastname: Kaban
authors.forename: B N
authors.initials: BN
authors.lastname: Liutov
authors.forename: N V
authors.initials: NV
authors.lastname: Shevchenko
authors.forename: T S
authors.initials: TS
authors.lastname: Litvinova
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009369:Neoplasms / Q000150:complications / Q000601:surgery; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D010149:Postoperative Pain / Q000188:drug therapy* / Q000209:etiology; D010166:Palliative Care; D014147:Tramadol / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D004304:Dosage Forms; D014147:Tramadol